Hisatomi T - Search Results

1

[Study on reoperation in cardiac disease].

Isomura T, Hisatomi T, Satou R, Matsuzoe S, Hirano A, Kosuga K, Ohishi K. Isomura T, et al. Among authors: hisatomi t. Kyobu Geka. 1992 Mar;45(3):208-11. Kyobu Geka. 1992. PMID: 1552672 Japanese.

2

Safety and efficacy of brilliant blue g250 (BBG) for lens capsular staining: a phase III physician-initiated multicenter clinical trial.

Hisatomi T, Enaida H, Yoshida S, Hirakata A, Ohji M, Nishida K, Kubota T, Ogata N, Matsui T, Kimura K, Sonoda KH, Uchiyama M, Kishimoto J, Todaka K, Nakanishi Y, Ishibashi T. Hisatomi T, et al. Jpn J Ophthalmol. 2020 Sep;64(5):455-461. doi: 10.1007/s10384-020-00763-y. Epub 2020 Aug 18. Jpn J Ophthalmol. 2020. PMID: 32809075

3

Staining ability and biocompatibility of brilliant blue G: preclinical study of brilliant blue G as an adjunct for capsular staining.

Hisatomi T, Enaida H, Matsumoto H, Kagimoto T, Ueno A, Hata Y, Kubota T, Goto Y, Ishibashi T. Hisatomi T, et al. Arch Ophthalmol. 2006 Apr;124(4):514-9. doi: 10.1001/archopht.124.4.514. Arch Ophthalmol. 2006. PMID: 16606877

4

Brilliant blue G selectively stains the internal limiting membrane/brilliant blue G-assisted membrane peeling.

Enaida H, Hisatomi T, Hata Y, Ueno A, Goto Y, Yamada T, Kubota T, Ishibashi T. Enaida H, et al. Among authors: hisatomi t. Retina. 2006 Jul-Aug;26(6):631-6. doi: 10.1097/01.iae.0000236469.71443.aa. Retina. 2006. PMID: 16829804 Clinical Trial.

5

Biocompatibility of brilliant blue G in a rat model of subretinal injection.

Ueno A, Hisatomi T, Enaida H, Kagimoto T, Mochizuki Y, Goto Y, Kubota T, Hata Y, Ishibashi T. Ueno A, et al. Among authors: hisatomi t. Retina. 2007 Apr-May;27(4):499-504. doi: 10.1097/IAE.0b013e318030a129. Retina. 2007. PMID: 17420705

6

Crucial role of P2X₇ receptor for effector T cell activation in experimental autoimmune uveitis.

Takeda A, Yamada H, Hasegawa E, Arima M, Notomi S, Myojin S, Yoshimura T, Hisatomi T, Enaida H, Yanai R, Kimura K, Ishibashi T, Sonoda KH. Takeda A, et al. Among authors: hisatomi t. Jpn J Ophthalmol. 2018 May;62(3):398-406. doi: 10.1007/s10384-018-0587-4. Epub 2018 Mar 23. Jpn J Ophthalmol. 2018. PMID: 29572578

7

Night-vision aid using see-through display for patients with retinitis pigmentosa.

Ikeda Y, Nakatake S, Funatsu J, Fujiwara K, Tachibana T, Murakami Y, Hisatomi T, Yoshida S, Enaida H, Ishibashi T, Sonoda KH. Ikeda Y, et al. Among authors: hisatomi t. Jpn J Ophthalmol. 2019 Mar;63(2):181-185. doi: 10.1007/s10384-018-00644-5. Epub 2019 Jan 2. Jpn J Ophthalmol. 2019. PMID: 30604110

8

An analysis of BIGH3 mutations in patients with corneal dystrophies in the Kyushu district of Japan.

Yoshida S, Kumano Y, Yoshida A, Hisatomi T, Matsui H, Nishida T, Ishibashi T, Matsui T. Yoshida S, et al. Among authors: hisatomi t. Jpn J Ophthalmol. 2002 Jul-Aug;46(4):469-71. doi: 10.1016/s0021-5155(02)00528-2. Jpn J Ophthalmol. 2002. PMID: 12225829

9

Preclinical investigation of internal limiting membrane staining and peeling using intravitreal brilliant blue G.

Enaida H, Hisatomi T, Goto Y, Hata Y, Ueno A, Miura M, Kubota T, Ishibashi T. Enaida H, et al. Among authors: hisatomi t. Retina. 2006 Jul-Aug;26(6):623-30. doi: 10.1097/01.iae.0000236470.71443.7c. Retina. 2006. PMID: 16829803

10

Development of a new mouse model of branch retinal vein occlusion and retinal neovascularization.

Zhang H, Sonoda KH, Qiao H, Oshima T, Hisatomi T, Ishibashi T. Zhang H, et al. Among authors: hisatomi t. Jpn J Ophthalmol. 2007 Jul-Aug;51(4):251-7. doi: 10.1007/s10384-007-0445-2. Epub 2007 Aug 3. Jpn J Ophthalmol. 2007. PMID: 17660984

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

309 results

Search Page

Filters